Actinium Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Actinium Pharmaceuticals's estimated annual revenue is currently $7.5M per year.
- Actinium Pharmaceuticals's estimated revenue per employee is $122,951
- Actinium Pharmaceuticals's total funding is $106.1M.
Employee Data
- Actinium Pharmaceuticals has 61 Employees.
- Actinium Pharmaceuticals grew their employee count by 20% last year.
Actinium Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and Chairman | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | VP, Head Radiation Sciences, Isotope Development and Supply Chain | Reveal Email/Phone |
4 | VP Clinical Development | Reveal Email/Phone |
5 | VP, Patent and Legal Counsel | Reveal Email/Phone |
6 | Head Human Resources | Reveal Email/Phone |
7 | Head Supplier Quality | Reveal Email/Phone |
8 | VP Clinical Development, BMT and Cellular Therapy | Reveal Email/Phone |
9 | Head Quality Control | Reveal Email/Phone |
10 | VP, Strategic Finance and Analysis | Reveal Email/Phone |
Actinium Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $376.5M | 2073 | 4% | N/A | N/A |
#2 | $1.1M | 11 | 83% | N/A | N/A |
#3 | $7.5M | 61 | 20% | $106.1M | N/A |
#4 | $11.3M | 73 | N/A | N/A | N/A |
#5 | $18.6M | 120 | 33% | N/A | N/A |
#6 | $20.3M | 126 | 18% | N/A | N/A |
#7 | $1.7M | 5 | -44% | N/A | N/A |
#8 | $69.3M | 533 | 38% | N/A | N/A |
#9 | $28.7M | 185 | 5% | N/A | N/A |
#10 | $25M | 161 | 55% | N/A | N/A |
What Is Actinium Pharmaceuticals?
Actinium Pharmaceuticals, Inc. is engaged in the development and commercialization of alpha particle immunotherapeutics based on its unique patent position for the utilization of actinium-225 and bismuth-213. It has facilities in Florham Park, New Jersey and Oak Ridge, Tennessee.
keywords:N/A
$106.1M
Total Funding
61
Number of Employees
$7.5M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Actinium Pharmaceuticals News
Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation & Cellular Therapy Tandem Meetings...
Data Supports Actinium Pharmaceutical's research collaboration with AVEO Oncology to develop and advance a HER3 targeted radiotherapy to...
Actinium Pharmaceuticals, Inc. and Immedica Announce Commercialization Agreement for Iomab-B (131I apamistamab) in Europe, the Middle East and...
Other Companies in Sydney
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.9M | 61 | -6% | N/A |
#2 | $24.5M | 61 | -8% | N/A |
#3 | $13.9M | 61 | 0% | N/A |
#4 | $11.7M | 61 | 17% | N/A |
#5 | $21.5M | 61 | -39% | N/A |